Tolbert 1993.
Methods | Randomized double‐blind placebo controlled, asymmetric cross‐over trial; 10 week treatment blocks | |
Participants | Treated participants:10 males & 5 females diagnosed using DSM‐III‐R criteria (age range, 6 to 18) | |
Interventions | 1.B6+Mg (20 weeks) then Placebo 10 (weeks) 2.B6+Mg (10 weeks) then Placebo (10 weeks)then B6+Mg (10 weeks) Dosage: B6: 200mg/70kg weight Mg: 100mg/70kg weight | |
Outcomes | Sensory‐motor; social behaviour; affective behaviour; sensory responses; language | |
Notes | Reported data not in useable form for analysis; Control group not randomly assigned | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Unclear risk | B ‐ Unclear |